Stetz Gary S. — SEC Form 4 filings
SEC reporting owner CIK 1532793. 5 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2025-11-05 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 3,250,000 shares, $150,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 1 filing — 100,351 shares, $343,882 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 2,000,000 shares @ $0.05 ($100,000) in Hepion Pharmaceuticals, Inc., filed 2026-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Canton Strategic Holdings, Inc. (CNTN) | Director | 2 | — | 8 legs · 100,351 sh · $343,882 | 1 |
| Hepion Pharmaceuticals, Inc. (HEPA) | Interim CEO, Director | 3 | 2 legs · 3,250,000 sh · $150,000 | — | 2 |
Form 4 filings — Stetz Gary S.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Grant/award (A): 1,345,500 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase (P): 2,000,000 @ $0.05 · Purchase (P): 2,000,000 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Canton Strategic Holdings, Inc. (CNTN) | Sale (S): 10,000 @ $3.45 · Sale (S): 10,000 @ $3.45 · Sale (S): 15,000 @ $3.40 · Sale (S): 15,000 @ $3.41 · Sale (S): 15,000 @ $3.41 · Sale (S): 10,000 @ $3.40 · +2 more | EDGAR |
| 2026-04-27 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase (P): 1,250,000 @ $0.04 | EDGAR |
| 2025-11-05 | 4 | Tharimmune, Inc. (THAR) | Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1532793 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →